149 related articles for article (PubMed ID: 34995376)
21. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.
Song YJ; Kang MS
Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848
[TBL] [Abstract][Full Text] [Related]
22. Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor.
Sanjo H; Zajonc DM; Braden R; Norris PS; Ware CF
J Biol Chem; 2010 May; 285(22):17148-55. PubMed ID: 20348096
[TBL] [Abstract][Full Text] [Related]
23. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.
Matsushima A; Kaisho T; Rennert PD; Nakano H; Kurosawa K; Uchida D; Takeda K; Akira S; Matsumoto M
J Exp Med; 2001 Mar; 193(5):631-6. PubMed ID: 11238593
[TBL] [Abstract][Full Text] [Related]
24. A novel murine model of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Xu RC; Wang F; Sun JL; Abuduwaili W; Zhang GC; Liu ZY; Liu TT; Dong L; Shen XZ; Zhu JM
J Transl Med; 2022 Dec; 20(1):579. PubMed ID: 36494846
[TBL] [Abstract][Full Text] [Related]
25. Neuron-Specific Tumor Necrosis Factor Receptor-Associated Factor 3 Is a Central Regulator of Neuronal Death in Acute Ischemic Stroke.
Gong J; Li ZZ; Guo S; Zhang XJ; Zhang P; Zhao GN; Gao L; Zhang Y; Zheng A; Zhang XF; Xiang M; Li H
Hypertension; 2015 Sep; 66(3):604-16. PubMed ID: 26269654
[TBL] [Abstract][Full Text] [Related]
26. High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma.
Jin J; Ryu HS; Lee KB; Jang JJ
PLoS One; 2014; 9(2):e90247. PubMed ID: 24587299
[TBL] [Abstract][Full Text] [Related]
27. Roles of TRAF3 in T cells: many surprises.
Yi Z; Wallis AM; Bishop GA
Cell Cycle; 2015; 14(8):1156-63. PubMed ID: 25723057
[TBL] [Abstract][Full Text] [Related]
28. Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS.
Yuan D; Huang S; Berger E; Liu L; Gross N; Heinzmann F; Ringelhan M; Connor TO; Stadler M; Meister M; Weber J; Öllinger R; Simonavicius N; Reisinger F; Hartmann D; Meyer R; Reich M; Seehawer M; Leone V; Höchst B; Wohlleber D; Jörs S; Prinz M; Spalding D; Protzer U; Luedde T; Terracciano L; Matter M; Longerich T; Knolle P; Ried T; Keitel V; Geisler F; Unger K; Cinnamon E; Pikarsky E; Hüser N; Davis RJ; Tschaharganeh DF; Rad R; Weber A; Zender L; Haller D; Heikenwalder M
Cancer Cell; 2017 Jun; 31(6):771-789.e6. PubMed ID: 28609656
[TBL] [Abstract][Full Text] [Related]
29. Control of canonical NF-kappaB activation through the NIK-IKK complex pathway.
Zarnegar B; Yamazaki S; He JQ; Cheng G
Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3503-8. PubMed ID: 18292232
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic potential of IDH1R132C mutant in cholangiocarcinoma development in mice.
Ding N; Che L; Li XL; Liu Y; Jiang LJ; Fan B; Tao JY; Chen X; Ji JF
World J Gastroenterol; 2016 Feb; 22(6):2071-80. PubMed ID: 26877611
[TBL] [Abstract][Full Text] [Related]
31. Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling.
Wang PX; Zhang XJ; Luo P; Jiang X; Zhang P; Guo J; Zhao GN; Zhu X; Zhang Y; Yang S; Li H
Nat Commun; 2016 Feb; 7():10592. PubMed ID: 26882989
[TBL] [Abstract][Full Text] [Related]
32. MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.
Wang LJ; He CC; Sui X; Cai MJ; Zhou CY; Ma JL; Wu L; Wang H; Han SX; Zhu Q
Oncotarget; 2015 Mar; 6(8):5932-46. PubMed ID: 25803229
[TBL] [Abstract][Full Text] [Related]
33. NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells.
Sasaki Y; Calado DP; Derudder E; Zhang B; Shimizu Y; Mackay F; Nishikawa S; Rajewsky K; Schmidt-Supprian M
Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10883-8. PubMed ID: 18663224
[TBL] [Abstract][Full Text] [Related]
34. Tumor Necrosis Factor Receptor Associated Factor 3 Modulates Cartilage Degradation through Suppression of Interleukin 17 Signaling.
Hu G; Zhang N; Li J; Wang J; Wu W; Li J; Tong W; Zhao X; Dai L; Zhang X
Am J Pathol; 2020 Aug; 190(8):1701-1712. PubMed ID: 32416098
[TBL] [Abstract][Full Text] [Related]
35. Tumor-derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression.
Luo C; Xin H; Zhou Z; Hu Z; Sun R; Yao N; Sun Q; Borjigin U; Wu X; Fan J; Huang X; Zhou S; Zhou J
Hepatology; 2022 Oct; 76(4):982-999. PubMed ID: 35106794
[TBL] [Abstract][Full Text] [Related]
36. Cholangiocarcinomas can originate from hepatocytes in mice.
Fan B; Malato Y; Calvisi DF; Naqvi S; Razumilava N; Ribback S; Gores GJ; Dombrowski F; Evert M; Chen X; Willenbring H
J Clin Invest; 2012 Aug; 122(8):2911-5. PubMed ID: 22797301
[TBL] [Abstract][Full Text] [Related]
37. NIK stabilization in osteoclasts results in osteoporosis and enhanced inflammatory osteolysis.
Yang C; McCoy K; Davis JL; Schmidt-Supprian M; Sasaki Y; Faccio R; Novack DV
PLoS One; 2010 Nov; 5(11):e15383. PubMed ID: 21151480
[TBL] [Abstract][Full Text] [Related]
38. Targeting signaling factors for degradation, an emerging mechanism for TRAF functions.
Yang XD; Sun SC
Immunol Rev; 2015 Jul; 266(1):56-71. PubMed ID: 26085207
[TBL] [Abstract][Full Text] [Related]
39. Circular RNA SMARCA5 inhibits cholangiocarcinoma via microRNA-95-3p/tumor necrosis factor receptor associated factor 3 axis.
Wang G; Gao X; Sun Z; He T; Huang C; Li S; Long H
Anticancer Drugs; 2023 Oct; 34(9):1002-1009. PubMed ID: 36727735
[TBL] [Abstract][Full Text] [Related]
40. A TRAF3-NIK module differentially regulates DNA vs RNA pathways in innate immune signaling.
Parvatiyar K; Pindado J; Dev A; Aliyari SR; Zaver SA; Gerami H; Chapon M; Ghaffari AA; Dhingra A; Cheng G
Nat Commun; 2018 Jul; 9(1):2770. PubMed ID: 30018345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
